Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC).
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Péter
P
Holló
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Hajnalka
H
Jókai
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Judit
J
Hársing
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Gyöngyvér
G
Soós
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Sarolta
S
Kárpáti
Department of Dermatovenerology and Dermatooncology, Semmelweis University, Budapest, Hungary. Electronic address: knemeth@mcw.edu.
Krisztián
K
Németh
D000279:Administration, Cutaneous; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001205:Ascorbic Acid